Cancer genetics and therapeutics

211 - Double Heterozygotes and Carriers of Biallelic Pathogenic Variants Identified During Genetic Testing for Hereditary Cancer Risk at a Diagnostic Laboratory

Previous Eposter
209 - A Pilot Study Evaluating Genomic and Pharmacogenomic, Variants among Elderly Patients with Colorectal Cancer

Next Eposters
214 - Novel Association of NUP214 Gene Fusions in Acute Myeloid Leukemia
216 - The BAFopathies: A New Way to Conceptualize Disorders of the BAF Chromatin Remodeling Complex
218 - Atypical Presentation of Neurofibromatosis and Melanoma Associated with CDKN2A Gene Deletion  
220 - Lynch Syndrome Families with Breast Cancer: Majority of Observed Mutations Are in MSH6 and PMS2
225 - Delivering Care to the Individuals with Genetic Predisposition to Cancer –  A 20 Month-Experience in GeneHome
231 - “Seeing Stars”: Treatment of Profound Biotinidase Deficiency Identified via Whole Exome Sequencing Restores Vision Loss in 49-Year-Old Male
237 - Low Level Mosaicism in Turner Syndrome: Implications for Surveillance and Management
239 - CHAMPIONS: A Phase 1/2 Clinical Trial for Treatment of MPS II (Hunter Syndrome) with SB-913 ZFN-Mediated In Vivo Human Genome-Editing
240 - Early Diagnosis and Speed to Effect in Spinal Muscular Atrophy Type 1 (SMA1)
249 - Cascade Testing of Personalized Diabetes Medicine Program (PDMP) Probands is Efficient in Diagnosing At-Risk Individuals of Monogenic Diabetes